Ignite Creation Date:
2024-05-06 @ 3:27 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04633239
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2020-11-17
Brief Title:
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-11-17
First Submit QC Date:
November 17 2020
Study First Post Date:
2020-11-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-19
Last Update Post Date:
2024-07-15
Last Update Post Date Type:
ESTIMATED